Scholz, Stefan; Mittendorf, Thomas - In: Health Economics Review 4 (2014) 18, pp. 1-16
Background: Rheumatoid arthritis (RA) is a chronic, inflammatory disease with severe effects on the functional ability of patients. Due to the prevalence of 0.5 to 1.0 percent in western countries, new treatment options are a major concern for decision makers with regard to their budget impact....